Full Year 2021 Faron Pharmaceuticals Oy Earnings Call Transcript

Mar 25, 2022 / 12:00PM GMT
Markku Jalkanen - Faron Pharmaceuticals Ltd. - CEO & Founder

Hello, everyone. I'm Faron's CEO, Markku Jalkanen, and welcome to listen our annual results '21 presentation. I'm here with our CFO, Toni.

Toni Hänninen - Faron Pharmaceuticals Ltd. - CFO

Hey, everybody.

Markku Jalkanen - Faron Pharmaceuticals Ltd. - CEO & Founder

And as you know, we are a public company, and I would like to start by reminding you about the disclaimer. We will be making also forward-looking statements, and it's important that you understand that.

We have been focusing on our immune system and help the conditions where we built up a life-threatening conditions, and we do have three different target molecules. We can activate our immune system, and that is the key asset we have at the moment, and that is in the middle of this graph, the target molecule being Clevegen, and we can inhibit or block the activation of that receptor by using a humanized antibody called bexmarilimab, called BEX, to be more simple,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot